← naar grote beleggers
Frazier Life Sciences Management, L.P.
vermogensbeheerder · portefeuille $4.59 mld. · 41 posities · rapport per 30.06.2026
Aandelenposities rapport over 30.06.2026, ingediend op 14.08.2026; verandering — t.o.v. 31.03.2026 · 38
| Bedrijf | Aandelen | Waarde | % van de portefeuille | Verandering per Kwartaal |
|---|---|---|---|---|
| Trevi Therapeutics Inc US:TRVI | 0 (was 9 939 547) | — | — | verkocht |
| Evolus Inc US:EOLS | 0 (was 2 630 665) | — | — | verkocht |
| Valneva SE US:VALN | 0 (was 2 291 666) | — | — | verkocht |
| iBio, Inc. US:IBIO | 0 (was 1 953 467) | — | — | verkocht |
| Vor Biopharma Inc US:VOR | 0 (was 2 543 939) | — | — | verkocht |
| ACADIA PHARMACEUTICALS INC US:ACAD | 0 (was 1 438 198) | — | — | verkocht |
| Immunocore Holdings Ltd US:IMCR | 0 (was 484 782) | — | — | verkocht |
| Xilio Development Inc US:XLO | 0 (was 422 505) | — | — | verkocht |
| Aclaris Therapeutics Inc US:ACRS | 0 (was 4 925 374) | — | — | verkocht |
| KALVISTA PHARMACEUTICALS INC CUSIP 483497103 | 0 (was 4 961 108) | — | — | verkocht |
| Zai Lab Ltd US:ZLAB | 0 (was 1 902 320) | — | — | verkocht |
| Agios Pharm US:AGIO | 0 (was 1 256 080) | — | — | verkocht |
| Krystal Biotech Inc US:KRYS | 0 (was 481 307) | — | — | verkocht |
| ALKERMES PLC CUSIP G01767105 | 0 (was 700 647) | — | — | verkocht |
| Allogene Therapeutics Inc US:ALLO | 0 (was 3 796 668) | — | — | verkocht |
| Lexeo Therapeutics, Inc. US:LXEO | 0 (was 4 424 725) | — | — | verkocht |
| NEWAMSTERDAM PHARMA COMPANY CUSIP N62509109 | 0 (was 16 943 774) | — | — | verkocht |
| Arcutis Biotherapeutics Inc US:ARQT | 0 (was 9 874 511) | — | — | verkocht |
| MBX Biosciences, Inc. US:MBX | 0 (was 6 652 013) | — | — | verkocht |
| NEWAMSTERDAM PHARMA COMPANY CUSIP N62509117 | 0 (was 500 333) | — | — | verkocht |
| Ascendis Pharma AS US:ASND | 0 (was 133 333) | — | — | verkocht |
| MannKind Corp US:MNKD | 0 (was 5 900 000) | — | — | verkocht |
| Aura Biosciences Inc US:AURA | 0 (was 5 100 000) | — | — | verkocht |
| Maze Therapeutics, Inc. US:MAZE | 0 (was 4 567 274) | — | — | verkocht |
| Autolus Therapeutics Ltd US:AUTL | 0 (was 4 447 910) | — | — | verkocht |
| Mirum Pharmaceuticals Inc US:MIRM | 0 (was 7 679 684) | — | — | verkocht |
| BioCryst Pharmaceuticals Inc US:BCRX | 0 (was 4 009 240) | — | — | verkocht |
| Monte Rosa Therapeutics Inc US:GLUE | 0 (was 1 000 000) | — | — | verkocht |
| Palvella Therapeutics, Inc US:PVLA | 0 (was 882 400) | — | — | verkocht |
| BridgeBio Pharma Inc US:BBIO | 0 (was 3 448 139) | — | — | verkocht |
| Phathom Pharmaceuticals Inc US:PHAT | 0 (was 12 466 489) | — | — | verkocht |
| Cytokinetics Inc US:CYTK | 0 (was 1 159 879) | — | — | verkocht |
| Revolution Medicines, Inc. US:RVMD | 0 (was 675 686) | — | — | verkocht |
| Disc Medicine Inc. US:IRON | 0 (was 1 354 852) | — | — | verkocht |
| Savara Inc US:SVRA | 0 (was 9 720 852) | — | — | verkocht |
| Dyne Therapeutics Inc US:DYN | 0 (was 3 153 082) | — | — | verkocht |
| Tarsus Pharmaceuticals Inc US:TARS | 0 (was 728 644) | — | — | verkocht |
| Erasca Inc US:ERAS | 0 (was 24 675 188) | — | — | verkocht |
In bedrijven uit onze database 4
| Bedrijf | Belang | Aandelen | Rapportdatum |
|---|---|---|---|
| NewAmsterdam Pharma Company… | 15.13% | 18 088 902 | 2026-06-30 |
| Trevi Therapeutics Inc | 6.98% | 9 939 447 | 2026-06-30 |
| Aclaris Therapeutics Inc | 3.52% | 4 925 374 | 2026-06-30 |
| Zai Lab Ltd | 1.67% | 1 902 320 | 2026-06-30 |
advertentie